Mortality of patients with systemic lupus erythematosus admitted to the intensive care unit – A retrospective single-center study

Lee, 2013, All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre, Rheumatology (Oxford), 52, 905, 10.1093/rheumatology/kes391 Quintero, 2013, Autoimmune diseases in the intensive care unit. An update, Autoimmun Rev, 12, 380, 10.1016/j.autrev.2012.06.002 Camargo, 2005, Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature, Lupus, 14, 315, 10.1191/0961203305lu2082oa Coral, 2006, Outcome of patients with rheumatic diseases that requires attention in the medical intensive care unit, J Clin Rheumatol, 12, S77, 10.1097/01.rhu.0000226706.20443.b9 Cavallasca, 2010, Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit, J Clin Rheumatol, 16, 400, 10.1097/RHU.0b013e3181ffe517 Williams, 2002, Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome, Ann Rheum Dis, 61, 414, 10.1136/ard.61.5.414 Namendys-Silva, 2009, Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit, Lupus, 18, 1252, 10.1177/0961203309345720 Shen, 2013, Temporal trends in characteristics and outcome of intensive care unit patients with systemic lupus erythematosus in Taiwan: a national population-based study, Lupus, 22, 644, 10.1177/0961203313476356 Edwards, 2003, Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome, Lupus, 12, 672, 10.1191/0961203303lu452oa Han, 2013, Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit, Lupus, 22, 690, 10.1177/0961203313490240 Ginzler, 1978, Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus, Arthritis Rheum, 21, 37, 10.1002/art.1780210107 Díaz-Lagares, 2011, Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label, Arthritis Res Ther, 13, R112, 10.1186/ar3397 Danza, 2013, Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies, Lupus, 22, 1286, 10.1177/0961203313493032 Navarra, 2011, Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial, Lancet, 377, 721, 10.1016/S0140-6736(10)61354-2 Pons-Estel, 2010, Understanding the epidemiology and progression of systemic lupus erythematosus, Semin Arthritis Rheum, 39, 257, 10.1016/j.semarthrit.2008.10.007 Ansell, 1996, Study of critically ill patients with systemic lupus erythematosus, Crit Care Med, 24, 981, 10.1097/00003246-199606000-00018 Alzeer, 2004, Outcome of patients with systemic lupus erythematosus in intensive care unit, Lupus, 13, 537, 10.1191/0961203304lu1057oa Whitelaw, 2005, Survival of patients with SLE admitted to an intensive care unit-a retrospective study, Clin Rheumatol, 24, 223, 10.1007/s10067-004-1007-3 Hsu, 2005, Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study, Crit Care, 9, R177, 10.1186/cc3481 Vásquez Kunze, 2007, Lupus eritematoso sistémico en la Unidad de cuidados intensivos de medicina del Hospital Nacional Cayetano Heredia, Rev Med Hered [online], 18, 192, 10.20453/rmh.v18i4.889 Couto Dde, 2008, Characteristics of patients with systemic lupus erythematosus admitted to the intensive care unit in a brazilian teaching hospital, Rev Bras Ter Intensiva, 20, 249 Ranzani, 2011, Outcomes and organ dysfunctions of critically ill patients with systemic lupus erythematosus and other systemic rheumatic diseases, Braz J Med Biol Res, 44, 1184, 10.1590/S0100-879X2011007500132 Knaus, 1985, Apache II: a severity of disease classification system, Crit Care Med, 13, 818, 10.1097/00003246-198510000-00009 Feng, 2010, Inadequate antimicrobial treatment for nosocomial infection is a mortality risk factor for systemic lupus erythematous patients admitted to intensive care unit, Am J Med Sci, 340, 64, 10.1097/MAJ.0b013e3181e0ef9b Fatemi, 2017, Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit, Clin Rheumatol, 36, 2471, 10.1007/s10067-017-3808-1 Siripaitoon, 2015, A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality, Lupus, 24, 98, 10.1177/0961203314548884 Tikly, 2008, Lupus in the developing world—is it any different?, Best Pract Res Clin Rheumatol, 22, 643, 10.1016/j.berh.2008.05.003 Sherer, 2007, Outcome of patients having dermatomyositis admitted to the intensive care unit, Clin Rheumatol, 26, 1851, 10.1007/s10067-007-0588-z Shalev, 2006, Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases, Clin Exp Rheumatol, 24, 380 Haviv, 2017, Patients with vasculitides admitted to the intensive care unit: implications from a single-center retrospective study, J Intensive Care Med, 1 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Vincent, 1996, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med, 22, 707, 10.1007/BF01709751 Peleg, 2010, Hospital-acquired infections due to gram-negative bacteria, N Engl J Med, 362, 1804, 10.1056/NEJMra0904124